Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Endothelin ETA receptor blockade potentiates morphine analgesia but does not affect gastrointestinal transit in mice.

Matwyshyn GA, Bhalla S, Gulati A.

Eur J Pharmacol. 2006 Aug 14;543(1-3):48-53. Epub 2006 May 26.

PMID:
16814278
2.

cDNA cloning of the mouse bilirubin/phenol family of UDP-glucuronosyltransferase (mUGTbr2-like).

Chu Q, Lei W, Gudehithlu K, Matwyshyn GA, Bocchetta M, Kong AN.

Pharm Res. 1997 May;14(5):662-6. No abstract available.

PMID:
9165540
3.

Activation of signal transduction kinases by tamoxifen.

Duh JL, Yu R, Jiao JJ, Matwyshyn GA, Li W, Tan TH, Kong AN.

Pharm Res. 1997 Feb;14(2):186-9.

PMID:
9090707
4.

Regulation of gene expression of various phase I and phase II drug-metabolizing enzymes by tamoxifen in rat liver.

Hellriegel ET, Matwyshyn GA, Fei P, Dragnev KH, Nims RW, Lubet RA, Kong AN.

Biochem Pharmacol. 1996 Nov 22;52(10):1561-8.

PMID:
8937471
5.

Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents.

Fei P, Matwyshyn GA, Rushmore TH, Kong AN.

Pharm Res. 1996 Jul;13(7):1043-8.

PMID:
8842042
7.

Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.

Bhargava HN, Matwyshyn GA, Reddy PL, Veeranna.

Pharmacol Biochem Behav. 1994 May;48(1):87-91.

PMID:
8029307
8.

Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice.

Thorat SN, Barjavel MJ, Matwyshyn GA, Bhargava HN.

Brain Res. 1994 Apr 11;642(1-2):153-9.

PMID:
7518322
9.
10.

Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.

Reddy PL, Veeranna, Matwyshyn GA, Thorat SN, Bhargava HN.

Gen Pharmacol. 1994 Mar;25(2):355-61.

PMID:
8026736
11.

beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.

Bhargava HN, Matwyshyn GA, Rattan AK, Koo KL, Tejwani GA.

J Pharmacol Exp Ther. 1994 Feb;268(2):856-61.

PMID:
8113998
12.

Effects of naltrexone pellet implantation on morphine tolerance and physical dependence in the rat.

Bhargava HN, Matwyshyn GA, Gerk PM, Bozek PS, Bailey MD, Ko KH, Simko RJ, Thorat SN.

Gen Pharmacol. 1994 Jan;25(1):149-55.

PMID:
8026700
13.
15.
16.

Brain and pituitary receptors for thyrotropin-releasing hormone in hypothyroid rats.

Bhargava HN, Ramarao P, Gulati A, Matwyshyn GA, Prasad R.

Pharmacology. 1989;38(4):243-52.

PMID:
2755964
17.

The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of hyperthyroid rats.

Bhargava HN, Ramarao P, Gulati A, Matwyshyn GA, Prasad R.

Arch Int Pharmacodyn Ther. 1989 Jan-Feb;297:247-59.

PMID:
2499290
18.
19.
21.

Effect of acute and chronic morphine administration on brain cholinergic muscarinic receptors.

Das S, Matwyshyn GA, Bhargava HN.

Gen Pharmacol. 1986;17(2):173-8.

PMID:
3699442
22.
23.

Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.

Bhargava HN, Matwyshyn GA.

Psychopharmacology (Berl). 1985;87(2):141-6.

PMID:
2996045
25.
26.

Interactions of thyrotropin releasing hormone, its metabolites and analogues with endogenous and exogenous opiates.

Bhargava HN, Yousif DJ, Matwyshyn GA.

Gen Pharmacol. 1983;14(6):565-70. Review.

PMID:
6141121
27.
29.

Brain serotonin turnover and morphine tolerance-dependence induced by multiple injections in the rat.

Bhargava HN, Matwyshyn GA.

Eur J Pharmacol. 1977 Jul 1;44(1):25-33.

PMID:
560305

Supplemental Content

Loading ...
Support Center